AKEBIA THERAPEUTICS Earnings Preview: Recent $AKBA Insider Trading, Hedge Fund Activity, and More

AKEBIA THERAPEUTICS ($AKBA) is expected to release its quarterly earnings data on Thursday, March 13th before market open, per Finnhub. Analysts are expecting revenue of $38,095,643 and earnings of -$0.08 per share.

You can see Quiver Quantitative's $AKBA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

AKEBIA THERAPEUTICS Insider Trading Activity

AKEBIA THERAPEUTICS insiders have traded $AKBA stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $AKBA stock by insiders over the last 6 months:

• JOHN P. BUTLER (CEO and President) has made 0 purchases and 3 sales selling 190,659 shares for an estimated $387,853.
• NICHOLAS GRUND (Chief Commercial Officer) sold 55,621 shares for an estimated $116,804
• STEVEN KEITH BURKE (SVP, Chief Medical Officer) has made 0 purchases and 2 sales selling 50,506 shares for an estimated $106,062.
• RICHARD C MALABRE (SVP, Chief Accounting Officer) sold 30,202 shares for an estimated $63,424

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AKEBIA THERAPEUTICS Hedge Fund Activity

We have seen 65 institutional investors add shares of AKEBIA THERAPEUTICS stock to their portfolio, and 49 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ACADIAN ASSET MANAGEMENT LLC removed 4,063,383 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $5,363,665
• STATE STREET CORP added 2,874,171 shares (+83.8%) to their portfolio in Q4 2024, for an estimated $5,460,924
• CITADEL ADVISORS LLC added 1,382,146 shares (+inf%) to their portfolio in Q4 2024, for an estimated $2,626,077
• VANGUARD GROUP INC added 813,902 shares (+8.1%) to their portfolio in Q4 2024, for an estimated $1,546,413
• JACOBS LEVY EQUITY MANAGEMENT, INC removed 805,459 shares (-39.6%) from their portfolio in Q4 2024, for an estimated $1,530,372
• MORGAN STANLEY added 701,159 shares (+64.4%) to their portfolio in Q4 2024, for an estimated $1,332,202
• GOLDMAN SACHS GROUP INC added 516,925 shares (+106.5%) to their portfolio in Q4 2024, for an estimated $982,157

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.